Jazz Pharma PLC Live Stock Price Today, Share Analysis and Chart

Name: Jazz Pharmaceuticals plc: Is Infosys Ltd. worth buying?
Item: Jazz Pharmaceuticals plc
Rating: 2.576458375
Author: Trendlyne DVM scores

Mid-range Performer

about

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

241.46 0.72 (0.30%)

91.97% Gain from 52W Low

499.2K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Medium Financial Strength

50.0 / 100

Affordable Valuation

55.2 / 100

Technically Neutral

51.0 / 100

Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM

291

1Yr Price target upside is 20%

20 analysts

Jazz Pharma PLC Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Jazz Pharma PLC Live Stock Price Today, Share Analysis and Chart

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

91.97% Gain from 52W Low

SWOT Analysis

Jazz Pharma PLC Live Price Chart

Jazz Pharma PLC Live Price Chart